Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:investor
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
Life sciences investments
Healthcare investments Biotechnology investments |
| gptkbp:foundedIn |
2006
|
| gptkbp:headquartersLocation |
gptkb:Austin,_Texas,_United_States
|
| gptkbp:industry |
Venture capital
|
| gptkbp:investedIn |
Early-stage companies
|
| gptkbp:managingPartner |
gptkb:Doug_French
Kevin Lalande |
| gptkbp:portfolioCompany |
gptkb:Aeglea_BioTherapeutics
gptkb:Millipede gptkb:Claret_Medical gptkb:TissueGen AbVitro Cerebrotech Medical Systems Geneos Therapeutics LDR Holding |
| gptkbp:website |
https://www.sante.com/
|
| gptkbp:bfsParent |
gptkb:Bill_Trainor
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sante Ventures
|